The State Council announced at its meeting that the list of base drugs will be increased to 685

According to the latest CCTV news broadcast on August 30, the premier of the State Council presided over the executive meeting of the State Council, listened to the report on the implementation of this year's tax reduction and fee reduction policies and measures, and decided to push forward new measures to support the development of the real economy; deployed and improved the national basic drug system to ensure the basic drug demand of the masses and reduce the burden of drug costs The meeting pointed out that improving the national basic drug system is an important measure to deepen medical reform and is conducive to meeting the basic drug demand of the masses It was determined at the meeting that, first, the catalogue of essential drugs should be adjusted in time On the basis of covering the main clinical diseases, 187 kinds of Chinese and Western medicines, including 12 kinds of tumor drugs and 22 kinds of drugs urgently needed for children, were transferred to focus on cancer, pediatrics and chronic diseases, which were significantly higher than the original catalogue After adjustment, the total varieties were expanded to 685 In the future, drugs newly approved for marketing, with significantly improved curative effect and reasonable price will be transferred in more quickly Second, we should reduce the burden of patients' drug costs We will promote the centralized procurement of public medical institutions, and reduce drug prices We will establish a mechanism for the linkage of basic drugs and basic medical insurance and ensure the sustainability of medical insurance, and give priority to the therapeutic drugs in the directory of basic drugs, so as to make medical insurance more beneficial to the insured Third, we should ensure the continuous supply of essential drugs For the essential drugs that are easy to be short due to small dosage, fixed-point production and storage can be adopted to ensure the supply At the same time, we should strengthen the supervision of drug quality and safety to ensure the safety of the masses This CCTV news broadcast published information about national essential drugs There is no doubt that eight signals have been released to the outside world: the national essential drugs catalogue will be published soon, and the quantity adjustment has been very clear, namely 685 kinds "Centralized procurement of public hospitals" focuses on "promoting" implementation and "carrying capacity" of procurement, that is, on the basis of Article 7, Article 70 and Article 17 of the State Council, it is possible to enrich and improve the current drug procurement system, and it is less likely to carry out system design again Price reduction is still the main theme In connection with the recent announcement on special procurement of imported anticancer drugs issued by Shaanxi and other 14 provinces (regions), the downward spiral of drug prices will be the mainstream The basis of this adjustment is to cover the main clinical diseases Combined with the current national clinical pathway program policies, from the perspective of drug use, it is a general trend to shift from project dues to payment by disease, and finally to payment by disease diagnosis related group (DRGs) Enterprises should focus on the collection of evidence of clinical value of drugs, and also bear the test of pharmacoeconomics Combined with the recent publication of key drug monitoring catalogue in Fuyang, Huangshan and other places in Anhui Province, a large number of auxiliary drugs will face the situation that they will not be able to enter the basic drugs, and will be cut off from the perspective of medical insurance reimbursement There will be unprecedented caution or limited efforts in the supplementation of basic drugs At the beginning of the medical reform, the concept of "basic drugs" was defined when the "national basic drug system" was established That is to say, "basic drugs are drugs that meet the needs of basic medical and health, have appropriate dosage forms, reasonable prices, can guarantee the supply and are fairly accessible to the public." As time goes by, with the liberalization of drug use at the grass-roots level, in addition to "reasonable price", the conditions of "adapting to the needs of basic medical and health care, appropriate dosage forms, and being able to guarantee supply" are gradually realized In addition, the existence of basic drugs must be guaranteed by solid medical insurance funds At the same time, it is not difficult to see from the comprehensive policies and information disclosed in all aspects that the new version of national drug base weighs more than ever before on the accessibility, safety and effectiveness of drugs Evidence-based medicine and pharmacoeconomics will become the important basis for the formulation of the new version of basic drugs, and the scientificity of variety selection will be further improved Therefore, before the national drug base can be basically guaranteed In addition, it is irrational for the local government to blindly supplement and expand the capacity of basic drugs with the mentality of "pursuing profits" Small dosage and other basic drugs that are easy to lead to shortage, quality and stable supply are the key points In the past, the price of drugs in short supply has often been cut to death Therefore, for such drugs, quality priority, appropriate price and stable supply will be the top priority "Establishing the mechanism of basic drugs, basic medical insurance linkage and ensuring the sustainability of medical insurance" is a pain point Since the establishment of China's basic drug system, three major medical insurance systems have made great contributions However, the ensuing inconsistency in the level of protection makes it difficult for the popularity and scientificity of essential drugs to be consistent for different insurance coverage Therefore, the few words mentioned in the meeting directly hit the key point of the popularization of essential drugs The newly established medical insurance bureau will integrate the medical insurance functions of urban employees, urban residents and the new rural cooperative medical insurance system, which can be said to be of great responsibility We will strengthen the supervision of drug quality and safety, and ensure that people can safely use drugs At the end of the meeting, this article emphasized once again the determination of the state not to leave a blind spot in drug quality supervision, not to leave a blind area, to keep the bottom line of drug safety, and to resolutely safeguard the health of the overwhelming majority of the people The author once again emphasizes the previous personal point of view, that is, when the national basic catalogue is issued, the impact on local finance should be considered, and whether the policy and local and medical institutions can achieve seamless integration of goals, interests and measures Only when the top-level design is closely combined with the actual operation, can the basic drugs truly realize the basic idea of "making medical institutions willing to match, medical staff willing to open, medical staff willing to use, and truly become the first choice of drugs for medical treatment" The basic drug system can truly get sustainable and healthy promotion I sincerely hope that the new version of the basic drugs and the subsequent supporting policies can be implemented as soon as possible, and further promote the development of the national pharmaceutical industry while continuing to improve the economy of drug use.